Cancer Genomics
Germline HRR Panel
$699
Evaluation of genes involved in Homologous Recombination Repair (HRR), important in assessing hereditary cancer risk and potential targeted therapies.
Targeted Therapy & Risk Assessment
Our HRR Panel provides advanced genetic testing designed to identify inherited risks associated with the DNA repair pathway. This information is critical for supporting precision medicine and informed treatment planning.
- Hereditary Risk: Assessment of mutations associated with prostate, ovarian, and pancreatic cancers.
- Treatment Guidance: Insights that may help identify candidates for PARP inhibitors and other targeted therapies.
- Expert Interpretation: High-quality technological analysis interpreted by experienced specialists.
Contact
Speak with our team
Reach us on WhatsApp for the fastest response, or send a message and we'll be in touch.
Message us on WhatsApp
info@angelsmedcare.com
Dubai, United Arab Emirates